Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.

Clinical trial NCT07044921 · RECRUITING

Trial details

NCT number: NCT07044921
Sponsor: Chinese PLA General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic

Start date: 2024-09-01
Primary completion: 2026-07-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.